עברית Rusia

Contact us


Shopping Cart

Your shopping cart is empty.
facebook

Scientific Studies

The US Space Agency (NASA) is encouraged with the results of Amorphical successful experiment in space!

The US Space Agency (NASA) is encouraged with the results of Amorphical successful experiment in space!

Accelerating the bone-building cells in space, will allow astronauts, at first, to stay longer in space station and soon also in Space Colony.
Now, more than 50 years after the first man landed on the moon, development of the Israeli company "Amorphical" is the preferred solution, with no side effects to prevent bone loss in space and of course, on earth.
Amorphous Calcium Carbonate Absorption is 2-Folds Higher

Amorphous Calcium Carbonate Absorption is 2-Folds Higher

Study results:
1. Absorption of amorphous calcium carbonate in the intestine is 2-folds higher than that of crystalline calcium carbonate — when the calcium is taken after a meal.
2. A single case showed that when taken on an empty stomach, amorphous calcium carbonate absorption in the intestine was 4.6-folds higher than crystalline calcium carbonate.


Amorphous Calcium Prevents Bone Loss and Assists in Maintaining Strong Bone

Amorphous Calcium Prevents Bone Loss and Assists in Maintaining Strong Bone

Amorphous calcium carbonate (ACC) demonstrated:
1. 50% reduction in bone loss vs. Caltrate (Pfizer) and Calcium-Citrate (GNC)
2. 34% increase in bone formation induction vs. Caltrate (Pfizer) and Calcium-Citrate (GNC).
3. 37% increase in mechanical strength vs. Caltrate (Pfizer) and Calcium-Citrate (GNC).


Amorphous Calcium Absorption is More Efficient

Amorphous Calcium Absorption is More Efficient

Absorption of amorphous calcium carbonate is better than that of crystalline calcium carbonate.
• 40% increase in gastrointestinal calcium absorption
• 30% increase in bone calcium absorption
• 27% increase in bone calcium retention
Gastrolith Researches

Gastrolith Researches

Amorphical consistently continues to explore the therapeutic advantages of the Gastrolith, in order to provide innovative medicine from nature for treating metabolic bone diseases.
Actively Recruiting Clinical Studies

Actively Recruiting Clinical Studies

Amorphical is currently conducting a number of clinical studies aimed to test the efficacy of amorphous calcium carbonate in several indications. Additional studies are being designed and are expected to be launched in the near future.
Future Studies

Future Studies

We believe that the advantages of our unique amorphous calcium carbonate products will contribute greatly to the well-being of millions of people worldwide.
Jump to page content

Content on this site is not considered advice, a recommendation or medical opinion and does not replace consultation with a doctor

Amorphical: Harash St. 11, Nes-Ziona, Israel

Office: 08-6995333

Информация, содержащаяся на этом сайте не является  советом, рекомендацией или  медицинским  мнением и не заменяет консультацию с врачом
Аморфикаль: Harash St. 11, Nes-Ziona, Israel
Офис: 08-6995333